1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow ADCT-701: new trials by email Literature Review of ADCT-701 trials Research Report on ADCT-701
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors ADCT-701 - Neuroendocrine Carcinomas, Neuroendocrine Tumors | Phase 1 | Recruiting | National Cancer Institute (NCI) | 70 | 2024-06-17 | 2026-11-09 |
Adrenocortical Carcinoma (1) · Carcinoma, Neuroendocrine (1) · Neuroblastoma (1) · Neuroendocrine Tumors (1) · Paraganglioma (1) · Pheochromocytoma (1)
National Cancer Institute (NCI) (1)
United States (1)